Novartis and Versant Ventures launch Borealis Biosciences, a discovery-stage biotech focused on developing next-generation RNA medicines for kidney diseases. https://lnkd.in/gYiCuauy
About us
Novartis is an innovative medicines company with research and development at its core. Our R&D engine powers an industry-leading pipeline dedicated to delivering transformative medicines to fight disease, restore possibilities and help people live life on their own terms. See our community guidelines: https://go.novartis.social/3Slt0Up
- Website
-
https://www.novartis.com/research-development
External link for Novartis Science
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Cambridge, MA
Updates
-
Novartis and Dren Bio, Inc. have agreed to collaborate on the discovery and advancement of novel, antibody-based immune cell engagers for certain cancers. The collaboration builds on the Novartis commitment to explore a range of modalities and approaches to bring new medicines with transformative potential to patients. https://lnkd.in/eBpWVhdE
-
Jennifer Brogdon, Head of Cell and Gene Therapies at Novartis Biomedical Research, discusses the trailblazing history of CAR-T development at Novartis, the field’s search for next-gen therapies, and highlights from her career as a scientist in an interview published on the Biomarker blog. https://lnkd.in/gn-zyuS3
-
-
Deadline approaching fast for applications to the Novartis Data Science Innovation Fellowship Program. Apply by July 29th to be considered for one of our 2-3 year fellowships for early-career scientists who are looking to apply their skills in data science and AI to drug discovery. Join our diverse and vibrant community of data experts dedicated to reimagining medicine for patients. Positions are available at our Basel (CH) and Cambridge, MA (US) Biomedical Research sites: https://lnkd.in/gSiuAfMt
-
-
Are you a recent PhD graduate with a passion for Data Science and Artificial Intelligence? Are you ready to apply and expand your skills to advance drug discovery and development for patients? Our Novartis Data Science Innovation Fellowship Program offers a unique opportunity to join a diverse and vibrant community of data researchers through a dedicated pharma training program for early-career scientists. We are accepting applications for 2-3 year fellowships at our Basel (CH) and Cambridge, MA (US) Biomedical Research sites through July 29. Imagine the career you could have at Novartis, and apply now: https://lnkd.in/gK-wiw6Y #datascience #datasciencecareers
-
In Science, our researchers identify a protein involved in the suppression of fetal hemoglobin, and report the discovery of small molecules that could potentially be used to degrade this novel target to treat sickle cell disease. https://lnkd.in/gh8Ft3g2 #hematology #sicklecelldisease #TPD
-
Novartis researchers have developed a new stretch device and 192-well cell stretch plate that enables high-throughput study of gene expression as cells respond to mechanical stress – an important factor in understanding cell biology and identifying potential targets for drug discovery. Read their paper in APL Bioengineering: https://lnkd.in/gvpFxM_8 #mechanobiology #drugdiscovery
A new cell stretch device for mechanobiology research in drug discovery
pubs.aip.org
-
Each year we welcome summer interns to our labs to apply their research skills and to learn about drug discovery and development. Many of these interns come to our Cambridge research site through the Summer of Science program, now in its 19th year. This year’s cohort includes 29 undergraduates from 25 different universities and research institutes. We wish a warm welcome and much success to all of our interns! Learn more about our internship programs here: https://lnkd.in/gKRRft6c #STEMinternships
-
-
Do you have a life sciences background? Are you curious about the world of drug discovery, or looking for a career with the potential to impact patients’ lives? Novartis, in collaboration with Davidson College and Coursera, is offering a six-course program on preclinical drug discovery. Learn more about the science and considerations behind the search for novel medicines in this self-paced online program: https://lnkd.in/gJHKUEQ2 Full description here: Drug Hunting: The Science of Making Medicines Preclinical drug discovery is a complex, challenging, and iterative hunt for novel new medicines to address the unmet medical needs of patients. The science and considerations behind this endeavour are covered in this online six course program, which begins with an Introduction to Drug Hunting, followed by in-depth discussions of Targets, Assays and Screening, Lead Selection and Optimization, Pharmacokinetics, Preclinical Safety, and Preformulation. Each course is self-paced, comprised of short 5-minute videos covering selected topics, accompanied by additional readings and problems designed to reinforce and deepen understanding of those topics. This program is intended for a graduate level audience with a life sciences background. #careerdevelopment #drugdiscovery #lifesciencecareers
Drug Hunting: The Science of Making New Medicines
coursera.org
-
Novartis announced an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company focused on developing novel radioligand therapies (RLTs) to treat cancers where there is high unmet patient need. https://lnkd.in/gqaSAgAT